Home > Insider Trading > Filing (0001209191-12-031819)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
949858	Oncogenex Pharmaceuticals Inc.	OGXI	In Vitro & In Vivo Diagnostic Substances (2835)	954343413

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1265782	A Martin Mattingly	1522 217Th Place Se Suite 100 Bothell WA 98021		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-06-01	1,000	$12.46	1,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common	Stock Option (right to buy)	Acquisiton	2012-05-31	4,000	$0.00	4,000	$12.56
Common	Restricted Stock Units	Acquisiton	2012-05-31	2,000	$0.00	2,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,000		2022-05-31	No	4	A	Direct
2,000			No	4	A	Direct

Footnotes

The options vest 100% on the earlier of May 31, 2013 or the date immediately prior to the issuer's next annual meeting of stockholders.
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
The restricted stock units vest 100% on the earlier of the first anniversary of the grant date or the date immediately prior to the issuer's next annual meeting of stockholders.
The restricted stock units expire 30 days from the earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders.